• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

    126.81 +4.12 (+3.36%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 575,913
    Open 123.73
    Bid (Size) 124.00 (2)
    Ask (Size) 135.00 (2)
    Prev. Close 122.69
    Today's Range 123.14 - 132.00
    52wk Range 51.04 - 136.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program
    From GeneDx
    Via Business Wire
    GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
    From GeneDx
    Via Business Wire

    Performance

    YTD
    +59.2%
    +59.2%
    1 Month
    -1.9%
    -1.9%
    3 Month
    +38.0%
    +38.0%
    6 Month
    +30.3%
    +30.3%
    1 Year
    +133.4%
    +133.4%

    More News

    Read More
    GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025
    From GeneDx
    Via Business Wire
    GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award
    From GeneDx
    Via Business Wire
    GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth
    From GeneDx
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference
    From GeneDx
    Via Business Wire
    GeneDx Holdings Corp (NASDAQ:WGS) Exhibits Strong Growth Momentum and Positive Technical Setup
    Via Chartmill
    GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors
    From GeneDx
    Via Business Wire
    Assessing GeneDx Holdings: Insights From 5 Financial Analysts
    Via Benzinga
    WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Seer Appoints Isaac Ro to its Board of Directors
    From Seer, Inc.
    Via GlobeNewswire
    WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx
    Via Business Wire
    WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Why GeneDx Holdings Stock Crushed It Again Today
    Via The Motley Fool
    What 4 Analyst Ratings Have To Say About GeneDx Holdings
    Via Benzinga
    GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. on Behalf of GeneDx Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Why GeneDx Holdings Stock Blasted 8% Higher Today
    Via The Motley Fool
    Sanmina, Sarepta Therapeutics, Polaris, Celestica And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga

    Frequently Asked Questions

    Is GeneDx Holdings Corp. - Class A Common Stock publicly traded?
    Yes, GeneDx Holdings Corp. - Class A Common Stock is publicly traded.
    What exchange does GeneDx Holdings Corp. - Class A Common Stock trade on?
    GeneDx Holdings Corp. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for GeneDx Holdings Corp. - Class A Common Stock?
    The ticker symbol for GeneDx Holdings Corp. - Class A Common Stock is WGS on the Nasdaq Stock Market
    What is the current price of GeneDx Holdings Corp. - Class A Common Stock?
    The current price of GeneDx Holdings Corp. - Class A Common Stock is 126.81
    When was GeneDx Holdings Corp. - Class A Common Stock last traded?
    The last trade of GeneDx Holdings Corp. - Class A Common Stock was at 10/09/25 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.